Abstract: RAI GuidePx: A robust predictor for radioactive iodine sensitivity status in papillary thyroid cancer leveraging thyroid differentiation genes.

Abstract: 0539American Thyroid Association Annual MeetingOct 30 – Nov 3, 2024This is early work describing the development of an algorithm for predicting resistance to RAI. The internal validation is excellent,…

Continue ReadingAbstract: RAI GuidePx: A robust predictor for radioactive iodine sensitivity status in papillary thyroid cancer leveraging thyroid differentiation genes.

Abstract: Molecular subtypes in radiation induced papillary thyroid cancer using Thyroid GuidePx.

Abstract: 0551American Thyroid Association Annual MeetingOct 30 - Nov 3, 2024Here we wanted to explore whether the biology captured by our prognostic test, Thyroid GuidePx, was present in radiation induced…

Continue ReadingAbstract: Molecular subtypes in radiation induced papillary thyroid cancer using Thyroid GuidePx.

A clinically useful and biologically informative genomic classifier for papillary thyroid cancer [2023]

Front. Endocrinol., 12 September 2023Sec. Thyroid EndocrinologyVolume 14 - 2023 Clinical management of papillary thyroid cancer depends on estimations of prognosis. Standard care, which relies on prognostication based on clinicopathologic…

Continue ReadingA clinically useful and biologically informative genomic classifier for papillary thyroid cancer [2023]